The Ganesha Lab in partnership with ChileGlobal Angels, a prominent network of angel investors in Chile, hosted BIOINVEST: the premier Latam Biotech Investment Event. This event showcased two cutting-edge startups to a select group of national and international investors.

Leading the presentations was metaBIX Biotech, a portfolio company of The Ganesha Lab, which introduced its AI-powered platform for detecting and monitoring pathogens in environmental settings. Their technology stands out by offering a two-week early warning system that can predict potential health risks in animal production.

Next, Positrigo, a Swiss startup, introduced its revolutionary PET imaging system designed for brain diagnostics, particularly in the early detection of Alzheimer’s Disease, addressing critical limitations in current diagnostic approaches.

Following these presentations, Camilo Anabalón, Life Sciences Portfolio Manager at The Ganesha Lab, delivered an insightful analysis of both companies’ progress and investment potential, engaging attendees in person and online.

“At The Ganesha Lab, we assess investment opportunities using specific metrics such as company maturity, growth rate, valuation, and key milestone achievements to display the potential impact and returns for investors,” Anabalón explained.

He emphasized that “our data-driven evaluation method equips investors with the tools needed to distinguish between promising and less viable investment opportunities, especially in pre-revenue companies.”

Anabalón then applied these metrics to evaluate both metaBIX Biotech and Positrigo, offering investors strategic insights on the timing and potential value of investments in these startups.

Held at Fundación Chile, the event was a success, with attendees expressing strong interest in the innovative startups and the robust evaluation framework provided by The Ganesha Lab.